Lepirudin
Overview
Lepirudin is a recombinant hirudin which is used as anticoaggulant in patients with heparin-induced thrombocytopenia who require parenteral antithrombotic treatment. Lepirudin is being invastigated in arterial thrombo-embolic disorders such as angina and MI (myocardial infarction).
Categories
- 10 Drugs affecting the blood
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Lepirudin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 150 mcg/kg of body weight | 150 (150) | As recommended. | IV | Followed after initial dose |
| 400 mcg/kg of body weight | 400 (400) | As recommended. | IV | Initial |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Lepirudin is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Lepirudin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Lepirudin
Back to top
Previous Drug Generic - Next Drug Generic